Microinjection of 2-arachidonoyl glycerol into the rat ventral hippocampus differentially modulates contextually induced fear, depending on a persistent pain state

European Journal of Neuroscience

Volumn 39, Issue 3, 2014, Pages 435-443

  Rea, Kieran ^a   Ford, Gemma K ^a   Olango, Weredeselam M ^a   Harhen, Brendan ^a   Roche, Michelle ^a   Finn, David P ^a  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

Aversion; Cannabinoid 1 (CB1) receptor; Endocannabinoid; Formalin; Periaqueductal grey

Indexed keywords

2 ARACHIDONOYLGLYCEROL; ANANDAMIDE; FORMALDEHYDE; RIMONABANT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AVERSION; CONDITIONING; CONTROLLED STUDY; EXPOSURE; FEAR; FOOTSHOCK; HIPPOCAMPUS; LIQUID CHROMATOGRAPHY; LOCOMOTION; MALE; MASS SPECTROMETRY; MICROINJECTION; NOCICEPTION; NONHUMAN; PAIN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; STARTLE REFLEX; TISSUE LEVEL; VENTRAL HIPPOCAMPUS;

AVERSION; CANNABINOID 1 (CB1) RECEPTOR; ENDOCANNABINOID; FORMALIN; PERIAQUEDUCTAL GREY;

ANIMALS; ARACHIDONIC ACIDS; CANNABINOID RECEPTOR AGONISTS; CANNABINOID RECEPTOR ANTAGONISTS; CONDITIONING, CLASSICAL; ENDOCANNABINOIDS; FEAR; FREEZING REACTION, CATALEPTIC; GLYCERIDES; HIPPOCAMPUS; INJECTIONS, INTRAVENTRICULAR; MICE; NOCICEPTION; PAIN; PIPERIDINES; POLYUNSATURATED ALKAMIDES; PYRAZOLES; RATS; RECEPTOR, CANNABINOID, CB1;

EID: 84893368679     PISSN: 0953816X     EISSN: 14609568     Source Type: Journal    
DOI: 10.1111/ejn.12452     Document Type: Article

References (69)

1. Asmundson, G.J. & Katz, J. (2009) Understanding the co-occurrence of anxiety disorders and chronic pain: state-of-the-art. Depress. Anxiety, 26, 888-901.
2. Bandler, R., Keay, K.A., Floyd, N. & Price, J. (2000) Central circuits mediating patterned autonomic activity during active vs. passive emotional coping. Brain Res. Bull., 53, 95-104.
3. Behbehani, M.M. (1995) Functional characteristics of the midbrain periaqueductal gray. Prog. Neurobiol., 46, 575-605.
4. Breivogel, C.S. & Childers, S.R. (1998) The functional neuroanatomy of brain cannabinoid receptors. Neurobiol. Dis., 5, 417-431.
5. Bremner, J.D. (2007) Neuroimaging in posttraumatic stress disorder and other stress-related disorders. Neuroimag. Clin. N. Am., 17, 523-538, ix.
6. Bremner, J.D., Randall, P., Scott, T.M., Bronen, R.A., Seibyl, J.P., Southwick, S.M., Delaney, R.C., McCarthy, G., Charney, D.S. & Innis, R.B. (1995) MRI-based measurement of hippocampal volume in patients with combat-related posttraumatic stress disorder. Am. J. Psychiat., 152, 973-981.
7. Butler, R.K. & Finn, D.P. (2009) Stress-induced analgesia. Prog. Neurobiol., 88, 184-202.
8. Butler, R.K., Rea, K., Lang, Y., Gavin, A.M. & Finn, D.P. (2008) Endocannabinoid-mediated enhancement of fear-conditioned analgesia in rats: opioid receptor dependency and molecular correlates. Pain, 140, 491-500.
9. Butler, R.K., Nilsson-Todd, L., Cleren, C., Léna, I., Garcia, R. & Finn, D.P. (2011) Molecular and electrophysiological changes in the prefrontal cortex-amygdala-dorsal periaqueductal grey pathway during persistent pain state and fear-conditioned analgesia. Physiol. Behav., 104, 1075-1081.
10. Butler, R.K., Ford, G.K., Hogan, M., Roche, M., Doyle, K.M., Kelly, J.P., Kendall, D.A., Chapman, V. & Finn, D.P. (2012) Fear-induced suppression of nociceptive behaviour and activation of Akt signalling in the rat periaqueductal grey: role of fatty acid amide hydrolase. J. Psychopharmacol., 26, 83-91.
11. Campos, A.C., Ferreira, F.R., Guimarães, F.S. & Lemos, J.I. (2010) Facilitation of endocannabinoid effects in the ventral hippocampus modulates anxiety-like behaviors depending on previous stress experience. Neuroscience, 167, 238-246.
12. Chiba, T. (2000) Collateral projection from the amygdalo-hippocampal transition area and CA1 to the hypothalamus and medial prefrontal cortex in the rat. Neurosci. Res., 38, 373-383.
13. Devane, W.A., Hanus, L., Breuer, A., Pertwee, R.G., Stevenson, L.A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A. & Mechoulam, R. (1992) Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science, 258, 1946-1949.
14. Felder, C.C., Nielsen, A., Briley, E.M., Palkovits, M., Priller, J., Axelrod, J., Nguyen, D.N., Richardson, J.M., Riggin, R.M., Koppel, G.A., Paul, S.M. & Becker, G.W. (1996) Isolation and measurement of the endogenous cannabinoid receptor agonist, anandamide, in brain and peripheral tissues of human and rat. FEBS Lett., 393, 231-235.
15. Finn, D.P., Beckett, S.R., Richardson, D., Kendall, D.A., Marsden, C.A. & Chapman, V. (2004) Evidence for differential modulation of conditioned aversion and fear-conditioned analgesia by CB1 receptors. Eur. J. Neurosci., 20, 848-852.
16. Finn, D.P., Jhaveri, M.D., Beckett, S.R., Madjd, A., Kendall, D.A., Marsden, C.A. & Chapman, V. (2006) Behavioral, central monoaminergic and hypothalamo-pituitary-adrenal axis correlates of fear-conditioned analgesia in rats. Neuroscience, 138, 1309-1317.
17. Floyd, N.S., Price, J.L., Ferry, A.T., Keay, K.A. & Bandler, R. (2000) Orbitomedial prefrontal cortical projections to distinct longitudinal columns of the periaqueductal gray in the rat. J. Comp. Neurol., 422, 556-578.
18. Ford, G.K., Kieran, S., Dolan, K., Harhen, B. & Finn, D.P. (2011) A role for the ventral hippocampal endocannabinoid system in fear-conditioned analgesia and fear responding in the presence of nociceptive tone in rats. Pain, 152, 2495-2504.
19. Freund, T.F. & Hájos, N. (2003) Excitement reduces inhibition via endocannabinoids. Neuron, 38, 362-365.
20. Geuze, E., Westenberg, H.G., Jochims, A., de Kloet, C.S., Bohus, M., Vermetten, E. & Schmahl, C. (2007) Altered pain processing in veterans with posttraumatic stress disorder. Arch. Gen. Psychiat., 64, 76-85.
21. Gondo, M., Moriguchi, Y., Kodama, N., Sato, N., Sudo, N., Kubo, C. & Komaki, G. (2012) Daily physical complaints and hippocampal function: an fMRI study of pain modulation by anxiety. NeuroImage, 63, 1011-1019.
22. Guindon, J. & Hohmann, A.G. (2009) The endocannabinoid system and pain. CNS Neurol. Disord.-Dr., 8, 403-421.
23. Gurvits, T.V., Shenton, M.E., Hokama, H., Ohta, H., Lasko, N.B., Gilbertson, M.W., Orr, S.P., Kikinis, R., Jolesz, F.A., McCarley, R.W. & Pitman, R.K. (1996) Magnetic resonance imaging study of hippocampal volume in chronic, combat-related posttraumatic stress disorder. Biol. Psychiat., 40, 1091-1099.
24. Hájos, N. & Freund, T.F. (2002) Distinct cannabinoid sensitive receptors regulate hippocampal excitation and inhibition. Chem. Phys. Lipids, 121, 73-82.
25. Hohmann, A.G. & Suplita, R.L. II (2006) Endocannabinoid mechanisms of pain modulation. AAPS J., 8, E693-E708.
26. Hohmann, A.G., Suplita, R.L., Bolton, N.M., Neely, M.H., Fegley, D., Mangieri, R., Krey, J.F., Walker, J.M., Holmes, P.V., Crystal, J.D., Duranti, A., Tontini, A., Mor, M., Tarzia, G. & Piomelli, D. (2005) An endocannabinoid mechanism for stress-induced analgesia. Nature, 435, 1108-1112.
27. Hoover, W.B. & Vertes, R.P. (2007) Anatomical analysis of afferent projections to the medial prefrontal cortex in the rat. Brain Struct. Funct., 212, 149-179.
28. Ishikawa, A. & Nakamura, S. (2003) Convergence and interaction of hippocampal and amygdalar projections within the prefrontal cortex in the rat. J. Neurosci., 23, 9987-9995.
29. Johnston, I.N., Maier, S.F., Rudy, J.W. & Watkins, L.R. (2012) Post-conditioning experience with acute or chronic inflammatory pain reduces contextual fear conditioning in the rat. Behav. Brain Res., 226, 361-368.
30. Katona, I., Sperlágh, B., Sík, A., Käfalvi, A., Vizi, E.S., Mackie, K. & Freund, T.F. (1999) Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons. J. Neurosci., 19, 4544-4558.
31. Kerr, D.M., Burke, N.N., Ford, G.K., Connor, T.J., Harhen, B., Egan, L.J., Finn, D.P. & Roche, M. (2012) Pharmacological inhibition of endocannabinoid degradation modulates the expression of inflammatory mediators in the hypothalamus following an immunological stressor. Neuroscience, 204, 53-63.
32. Kerr, D.M., Harhen, B., Okine, B.N., Egan, L.J., Finn, D.P. & Roche, M. (2013) The monoacylglycerol lipase inhibitor JZL184 attenuates LPS-induced increases in cytokine expression in the rat frontal cortex and plasma: differential mechanisms of action. Brit. J. Pharmacol., 169, 808-819.
33. Kirkham, T.C., Williams, C.M., Fezza, F. & Di Marzo, V. (2002) Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol. Brit. J. Pharmacol., 136, 550-557.
34. Kishi, T., Tsumori, T., Yokota, S. & Yasui, Y. (2006) Topographical projection from the hippocampal formation to the amygdala: a combined anterograde and retrograde tracing study in the rat. J. Comp. Neurol., 496, 349-368.
35. Kraus, A., Geuze, E., Schmahl, C., Greffrath, W., Treede, R.D., Bohus, M. & Vermetten, E. (2009) Differentiation of pain ratings in combat-related posttraumatic stress disorder. Pain, 143, 179-185.
36. Lafenêtre, P., Chaouloff, F. & Marsicano, G. (2007) The endocannabinoid system in the processing of anxiety and fear and how CB1 receptors may modulate fear extinction. Pharmacol. Res., 56, 367-381.
37. Liu, M.G. & Chen, J. (2009) Roles of the hippocampal formation in pain information processing. Neurosci. Bull., 25, 237-266.
38. Mackie, K. (2005) Distribution of cannabinoid receptors in the central and peripheral nervous system. Handb. of Exp. Pharmacol., 168, 299-325.
39. Maren, S., Phan, K.L. & Liberzon, I. (2013) The contextual brain: implications for fear conditioning, extinction and psychopathology. Nat. Rev. Neurosci., 14, 417-428.
40. Mechoulam, R., Ben-Shabat, S., Hanus, L., Ligumsky, M., Kaminski, N.E., Schatz, A.R., Gopher, A., Almog, S., Martin, B.R., Compton, D.R., Pertwee, R.G., Griffin, G., Bayewitch, M., Barg, J. & Vogel, Z. (1995) Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem. Pharmacol., 50, 83-90.
41. Mikics, E., Dombi, T., Barsvári, B., Varga, B., Ledent, C., Freund, T.F. & Haller, J. (2006) The effects of cannabinoids on contextual conditioned fear in CB1 knockout and CD1 mice. Behav. Pharmacol., 17, 223-230.
42. Moreira, F.A., Aguiar, D.C., Resstel, L.B., Lisboa, S.F., Campos, A.C., Gomes, F.V. & Guimaraes, F.S. (2012) Neuroanatomical substrates involved in cannabinoid modulation of defensive responses. J. Psychopharmacol., 26, 40-55.
43. Olango, W.M., Roche, M., Ford, G.K., Harhen, B. & Finn, D.P. (2012) The endocannabinoid system in the rat dorsolateral periaqueductal grey mediates fear-conditioned analgesia and controls fear expression in the presence of nociceptive tone. Brit. J. Pharmacol., 165, 2549-2560.
44. Olango, W.M., Géranton, S.M., Roche, M., Hunt, S.P. & Finn, D.P. (2013) Novel molecular correlates of endocannabinoid-mediated fear-conditioned analgesia in rats. Eur. J. Pain, doi: 10.1002/j.1532-2149.2013.00369.x [Epub ahead of print].
45. Paxinos, G. & Watson, C. (1998) The Rat Brain in Stereotaxic Coordinates. Academic Press, New York.
46. Pitkänen, A., Pikkarainen, M., Nurminen, N. & Ylinen, A. (2000) Reciprocal connections between the amygdala and the hippocampal formation, perirhinal cortex, and postrhinal cortex in rat. A review. Ann. N.Y. Acad. Sci., 911, 369-391.
47. Rauch, S.L., Shin, L.M. & Phelps, E.A. (2006) Neurocircuitry models of posttraumatic stress disorder and extinction: human neuroimaging research - past, present, and future. Biol. Psychiat., 60, 376-382.
48. Rea, K., Lang, Y. & Finn, D.P. (2009) Alterations in extracellular levels of gamma-aminobutyric acid in the rat basolateral amygdala and periaqueductal gray during conditioned fear, persistent pain and fear-conditioned analgesia. J. Pain, 10, 1088-1098.
49. Rea, K., Roche, M. & Finn, D.P. (2011) Modulation of conditioned fear, fear-conditioned analgesia, and brain regional c-Fos expression following administration of muscimol into the rat basolateral amygdala. J. Pain, 12, 712-721.
50. Rea, K., Olango, W.M., Harhen, B., Kerr, D.M., Galligan, R., Fitzgerald, S., Moore, M., Roche, M. & Finn, D.P. (2013) Evidence for a role of GABAergic and glutamatergic signalling in the basolateral amygdala in endocannabinoid-mediated fear-conditioned analgesia in rats. Pain, 154, 576-585.
51. Resstel, L.B., Moreira, F.A. & Guimarães, F.S. (2009) Endocannabinoid system and fear conditioning. Vitam. Horm., 81, 421-440.
52. Rizvi, T.A., Ennis, M., Behbehani, M.M. & Shipley, M.T. (1991) Connections between the central nucleus of the amygdala and the midbrain periaqueductal gray: topography and reciprocity. J. Comp. Neurol., 303, 121-131.
53. Roche, M., O'Connor, E., Diskin, C. & Finn, D.P. (2007) The effect of CB(1) receptor antagonism in the right basolateral amygdala on conditioned fear and associated analgesia in rats. Eur. J. Neurosci., 26, 2643-2653.
54. Roche, M., Johnston, P., Mhuircheartaigh, O.N., Olango, W.M., Mackie, K. & Finn, D.P. (2010) Effects of intra-basolateral amygdala administration of rimonabant on nociceptive behaviour and neuronal activity in the presence or absence of contextual fear. Eur. J. Pain, 14, 487-495.
55. Rockwell, C.E., Snider, N.T., Thompson, J.T., Vanden Heuvel, J.P. & Kaminski, N.E. (2006) Interleukin-2 suppression by 2-arachidonyl glycerol is mediated through peroxisome proliferator-activated receptor gamma independently of cannabinoid receptors 1 and 2. Mol. Pharmacol., 70, 101-111.
56. Roohbakhsh, A., Keshavarz, S., Hasanein, P., Rezvani, M.E. & Moghaddam, A.H. (2009) Role of endocannabinoid system in the ventral hippocampus of rats in the modulation of anxiety-like behaviours. Basic Clin. Pharmacol., 105, 333-338.
57. Rubino, T., Guidali, C., Vigano, D., Realini, N., Valenti, M., Massi, P. & Parolaro, D. (2008a) CB1 receptor stimulation in specific brain areas differently modulate anxiety-related behaviour. Neuropharmacology, 54, 151-160.
58. Rubino, T., Realini, N., Castiglioni, C., Guidali, C., Viganó, D., Marras, E., Petrosino, S., Perletti, G., Maccarrone, M., Di Marzo, V. & Parolaro, D. (2008b) Role in anxiety behavior of the endocannabinoid system in the prefrontal cortex. Cereb. Cortex, 18, 1292-1301.
59. Saunders, R.C., Rosene, D.L. & Van Hoesen, G.W. (1988) Comparison of the efferents of the amygdala and the hippocampal formation in the rhesus monkey: II. Reciprocal and non-reciprocal connections. J. Comp. Neurol., 271, 185-207.
60. Sigel, E., Baur, R., Rácz, I., Marazzi, J., Smart, T.G., Zimmer, A. & Gertsch, J. (2011) The major central endocannabinoid directly acts at GABA(A) receptors. Proc. Natl. Acad. Sci. USA, 108, 18150-18155.
61. Sugiura, T., Kondo, S., Sukagawa, A., Nakane, S., Shinoda, A., Itoh, K., Yamashita, A. & Waku, K. (1995) 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain. Biochem. Bioph. Res. Co., 215, 89-97.
62. Sugiura, T., Kondo, S., Kishimoto, S., Miyashita, T., Nakane, S., Kodaka, T., Suhara, Y., Takayama, H. & Waku, K. (2000) Evidence that 2-arachidonoylglycerol but not N-palmitoylethanolamine or anandamide is the physiological ligand for the cannabinoid CB2 receptor. Comparison of the agonistic activities of various cannabinoid receptor ligands in HL-60 cells. J. Biol. Chem., 275, 605-612.
63. Suplita, R.L. II, Farthing, J.N., Gutierrez, T. & Hohmann, A.G. (2005) Inhibition of fatty-acid amide hydrolase enhances cannabinoid stress-induced analgesia: sites of action in the dorsolateral periaqueductal gray and rostral ventromedial medulla. Neuropharmacology, 49, 1201-1209.
64. Thierry, A.M., Gioanni, Y., Dégénétais, E. & Glowinski, J. (2000) Hippocampo-prefrontal cortex pathway: anatomical and electrophysiological characteristics. Hippocampus, 10, 411-419.
65. Vachon-Presseau, E., Roy, M., Martel, M.O., Caron, E., Marin, M.F., Chen, J., Albouy, G., Plante, I., Sullivan, M.J., Lupien, S.J. & Rainville, P. (2013) The stress model of chronic pain: evidence from basal cortisol and hippocampal structure and function in humans. Brain, 136, 815-827.
66. Vianna, D.M. & Brandao, M.L. (2003) Anatomical connections of the periaqueductal gray: specific neural substrates for different kinds of fear. Braz. J. Med. Biol. Res., 36, 557-566.
67. Viveros, M.P., Marco, E.M., Llorente, R. & Lamota, L. (2007) The role of the hippocampus in mediating emotional responses to nicotine and cannabinoids: a possible neural substrate for functional interactions. Behav. Pharmacol., 18, 375-389.
68. Watson, G.S., Sufka, K.J. & Coderre, T.J. (1997) Optimal scoring strategies and weights for the formalin test in rats. Pain, 70, 53-58.
69. Zogopoulos, P., Vasileiou, I., Patsouris, E. & Theocharis, S.E. (2013) The role of endocannabinoids in pain modulation. Fund. Clin. Pharmacol., 27, 64-80.